An extension to a phase II study to determine the safety and the anti- leukemic effects of STI571 in adults patients with Philadelphia chromosome positive leukemia including acute lymphoblastic leuke...

Mise à jour : Il y a 4 ans
Référence : EUCTR2005-001381-14

An extension to a phase II study to determine the safety and the anti- leukemic effects of STI571 in adults patients with Philadelphia chromosome positive leukemia including acute lymphoblastic leukemia, acute myeloid leukemia and accelerate phase myeloid leukemia. Estensione dello studio in aperto di fase II per determinare la tollerabilita` e l`efficacia antileucemica di STI571 in pazienti adulti con leucemia Ph+ incluse la leucemia linfoblastica acuta, la leucemia mieloide acuta e la leucemia mieloide cronica in fase accelerata

Femme et Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

• To enable patients to have access to study drug and continue study treatment • To decrease data collection to include only overall survival and serious adverse events • Consentire ai pazienti gia` in trattamento di continuare l'assunzione di STI571. • Semplificare la raccolta dei dati che includera` solamente i dati sulla sopravvivenza e gli eventi avversi seri.


Critère d'inclusion

  • Philadelphia chromosome positive leukemia including acute lymphoblastic leukemia, acute myeloid leukemia and accelerate phase myeloid leukemia,leucemia Ph+ incluse la leucemia linfoblastica acuta, la leucemia mieloide acuta e la leucemia mieloide cronica in fase accelerata

Liens